Welcome to Edition 8.31 of the Rocket Report! We have some late-breaking news this week with an update Thursday afternoon ...
VTx-002 is a first-in-class vectorized antibody to holistically target TDP-43 pathology in ALS recently granted FDA Fast Track Designation for expedited review Amsterdam, The Netherlands, and Boston, ...
NASHVILLE, Tenn. (WSMV) - Clarice Phelps describes nuclear chemistry a little differently than most people would. “I got it relatively quickly, and it was easy, and I liked it, and it just kind of ...
The Honorable Governor Greg Abbott, United States Department of Energy Chief Commercial Officer Anthony Pugliese and Texas Railroad Commissioner Wayne Christian Join Element3 CEO Hood Whitson to ...
VectorY Therapeutics Announces First Participant Dosed in Phase 1/2 PIONEER-ALS Clinical Trial of VTx-002 in People with Amyotrophic Lateral Sclerosis (ALS) VTx-002 is a first-in-class vectorized ...
The story of the last element to be discovered out of the first 92 catalogued in the periodic table is told by Eric Scerri, who reminds us that technetium can be found a little closer to home than ...
This manuscript describing the phenotypes associated with loss and gain of RVCL-S documents important findings that have practical implications. Although the data and methods are solid and support ...